Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy (vol 27, pg 16, 2009)

被引：0
|
作者：
Olivotto
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 14期
关键词：
D O I：
10.1200/JCO.2009.23.1365
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2415 / 2415
页数：1
相关论文
共 50 条
  • [41] Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy
    Patel, Akshar N.
    Goyal, Sharad
    Wu, Hao
    Schiff, Devora
    Moran, Meena S.
    Haffty, Bruce G.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (03) : 601 - 607
  • [42] Information needs of older women with early-stage breast cancer when making radiation therapy decisions (vol 98, pg 733, 2017)
    Wang, S. Y.
    Kelly, G.
    Gross, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (02): : 532 - 532
  • [43] Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy
    Akshar N. Patel
    Sharad Goyal
    Hao Wu
    Devora Schiff
    Meena S. Moran
    Bruce G. Haffty
    Breast Cancer Research and Treatment, 2011, 126 : 601 - 607
  • [44] Can Radiation Therapy Be Omitted after Breast Conserving Surgery with or Without Chemotherapy for Older Women (> 70 years old) with Early Stage Triple-Negative Breast Cancer?
    Hsiao, K. Y.
    Haque, W.
    Verma, V.
    Hatch, S. S.
    Chang, J. C.
    Butler, E. B.
    Teh, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S229 - S229
  • [45] Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features
    Jagsi, R.
    Griffith, K.
    Harris, E. E.
    Wright, J. L.
    Recht, A.
    Taghian, A. G.
    Lee, L.
    Moran, M. S.
    Thomas, T. O., Jr.
    Johnstone, C.
    Rahimi, A. S.
    Freedman, G. M.
    Muzaffar, M.
    Haffty, B. G., Jr.
    Horst, K. C.
    Powell, S. N.
    Sharp, J.
    Sabel, M. S.
    Schott, A. F.
    El-Tamer, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S7 - S8
  • [46] Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy plus Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery
    Morris, Astrid D.
    Hanes, Douglas A.
    Kaplan, Henry G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (05): : 1134 - 1144
  • [47] Cosmetic Outcome Before and After External Beam or Intraoperative Radiation Therapy for Early Breast Cancer Within 1 Year of Breast-Conserving Surgery: An Objective Assessment of Patients From a Randomized Controlled Trial
    Williams, N. R.
    Wenz, F.
    Welzel, G.
    Michalopoulos, N.
    Keshtgar, M. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S220 - S220
  • [48] Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial (vol16, pg 47, 2015)
    Bartelink, H.
    Maingon
    Poortmans, P.
    LANCET ONCOLOGY, 2015, 16 (01): : E6 - E6
  • [49] Single modality adjuvant therapy with radiation (RT) alone or endocrine therapy (ET) alone in women ≥65 years with early stage, hormone receptor positive breast cancer treated with breast-conserving surgery: A population-based analysis
    Goldberg, Mira
    Sutradhar, Rinku
    Paszat, Lawrence
    Whelan, Timothy
    Gu, Sumei
    Fong, Cindy
    Rakovitch, Eileen
    CANCER RESEARCH, 2020, 80 (04)
  • [50] Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen (vol 26, pg 1948, 2008)
    不详
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3659 - 3659
12345